Haemophilia: Development of new therapy

Haemophilia is a disabling bleeding disorder which is caused by premature resolution of the clot that forms when a blood vessel is injured. The research hypotheses that antifibrinolytic therapy can be used to improve haemophilia care.

However, knowledge is lacking in the field. Therefore, the goal of the proposed project is to test the potential value of antifibrinolytic therapy in haemophilia using animal models of haemophilia and altered fibrinolysis.